Visualitzant O - Articles científics per títol

IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications

Burotto, Mauricio; Zvirbule, Z.; Mochalova, A.; Runglodvatana, Y.; Herraez-Baranda, L.; Liu, S.N.; FELIP, ENRIQUETA (Elsevier, 2023-08)

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Amor López, Ana; Mazariegos, Marina S.; Capuano, Alessandra; Ximénez-Embún, Pilar; Hergueta-Redondo, Marta; Recio Conde, Juan Angel; Muñoz Couselo, Eva (MDPI, 2021-07-09)

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Sabaté Gallego, Mònica; Pérez Esquirol, Eulalia; García Doladé, Núria; Vidal Guitart, Xavier; Farriols Danes, Anna Maria; Felip Font, Enriqueta; Braña Garcia, Irene; Carles Galceran, Joan; Morales Barrera, Rafael; Agustí Escasany, Maria Antònia; Carreras Soler, Maria Josep; Muñoz Couselo, Eva (Frontiers Media, 2022-08-22)

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Miguel-Huguet, Bernat; Perez-Garcia, Jose Manuel; Páez, David; Guerrero‑Zotano, Angel; Garde-Noguera, Javier; Cortés Castan, Javier; Sampayo-Cordero, Miguel (Elsevier, 2020-11-01)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Mavaddat, Nasim; Ficorella, Lorenzo; Carver, Tim; Lee, Andrew; Cunningham, Alex P.; Lush, Michael; Pardo Muñoz, Monica; Balmaña Gelpí, Judith (American Association for Cancer Research, 2023-03-01)

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Bartoletti, Michele; Montico, Marcella; Lorusso, Domenica; Mazzeo, Roberta; OAKNIN, ANA; Musacchio, lucia (Elsevier, 2024-02-27)

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Capdevila Castillon, Jaume; Sherman, Steven; Jarząb, Barbara (Mary Ann Liebert, 2024-03)

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Perez, Ariel; Jurinovic, Vindi; Holtick, Udo; Rejeski, Kai; IACOBONI, GLORIA; Bücklein, Veit (Wolters Kluwer Health, 2023-07-11)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

Ramiro Pascual, Laura; Faura Llorens, Julia; Simats Oriol, Alba; Garcia Rodriguez, Paula; Ma, Feifei; Martín Castel, Luna; Canals Suris, Francesc; Montaner Villalonga, Joan; Rosell Novel, Anna (BMC, 2023-01-27)

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Li, Qing; Jiang, Baishan; Guo, Jiaye; Shao, Hong; Del Priore, Isabella; Chang, Qing; Palafox Sánchez, Marta; Serra Elizalde, Violeta (American Association for Cancer Research, 2022-02-01)

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Arellano-Rodrigo, Eduardo; Garrote Ordeig, Marta; Martín, Iván; GOMEZ CASARES, MARIA TERESA; Mosquera Orgueira, Adrián; Pérez-Encinas, Manuel; Fox, Maria Laura (Wiley, 2024-03-20)

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

Pascual Reguant, Laura; Serra Camprubí, Queralt; Datta, Debayan; Cianferoni, Damiano; Kourtis, Savvas; Gañez Zapater, Antoni; Miró Canturri, Andrea; Guzman Torres, Marta; Rodríguez, Olga; Querol, Jessica; Herencia Ropero, Andrea; Arribas, Joaquin; Serra, Violeta; TIAN, TIAN; Peiró, Sandra (EMBO Press, 2023-12-07)

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

Ben Aim, Laurene; MAHER, EAMONN; Cascon, Alberto; Barlier, Anne; Giraud, Sophie; Ercolino, Tonino; Toledo, Rodrigo (BMJ, 2022-08)

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

Callejo Perez, Ana; Iranzo Gómez, Patricia; Diaz-Mejia, Nely; Marmolejo Castañeda, David; Assaf, Juan David; Cedres Perez, Susana; Martínez Marti, Alexandre; Navarro Mendivil, Alejandro; Pardo Aranda, Nuria; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (MDPI, 2021-07)

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs

Felip Font, Enriqueta; Shaw, Alice Tsang; Bearz, A.; Camidge, D. R.; Bauman, J. R.; Solomon, Benjamin (Elsevier, 2021-05)

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?

ray coquard, isabelle; Lorusso, Domenica; OAKNIN, ANA; Cibula, David; Vergote, Ignace; Van Gorp, Toon (Taylor & Francis, 2023)

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

Dent, Rebecca; O’Shaughnessy, Joyce; Kim, Sung‑Bae; Isakoff, S. J.; Barrios, Carlos; Antunes de Melo Oliveira, Ana Mafalda; Turner, Nicholas (Springer, 2022-02)

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

Garralda Cabanas, Elena; Eskens, Ferry; Gil-Martin, Marta; Yen, Chia-Jui; Santoro, Armando; Simonelli, Matteo (Elsevier, 2022-10)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

Fuentes Varela, Pedro; Sese Faustino, Marta; Guijarro Carrillo, Pedro Jesus; Emperador Melero, Marta Isabel; Sánchez-Redondo, Sara; Peinado, Héctor; Hümmer, Stefan; Ramon y Cajal Agüeras, Santiago (Nature Research, 2020-08-26)

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

Tabernero Caturla, Josep; Van Cutsem, Eric; Fuchs, Charles; Janjigian, Yelena; Bhagia, Pooja; Bang, Yung-Jue (Future Medicine, 2021-08)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis ﻿

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice ﻿

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design ﻿

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model ﻿

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis ﻿

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study ﻿

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use ﻿

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia ﻿

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors ﻿

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis ﻿

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer ﻿

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma ﻿

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients ﻿

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs ﻿

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline? ﻿

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial ﻿

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study ﻿

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells ﻿

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple‐negative breast cancer

International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma

Interrelations between Patients’ Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients

Intracranial and extracranial efficacy of lorlatinib in patients with ALK-positive non-small-cell lung cancer previously treated with second-generation ALK TKIs

Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?

Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma